HomeCompareSTSA vs PM

STSA vs PM: Dividend Comparison 2026

STSA yields 136.36% · PM yields 3.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 STSA wins by $15.51M in total portfolio value
10 years
STSA
STSA
● Live price
136.36%
Share price
$1.10
Annual div
$1.50
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15.56M
Annual income
$6,371,447.45
Full STSA calculator →
PM
Philip Morris International
● Live price
3.49%
Share price
$164.83
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,502.61
Full PM calculator →

Portfolio growth — STSA vs PM

📍 STSA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSTSAPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, STSA + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
STSA pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

STSA
Annual income on $10K today (after 15% tax)
$11,590.91/yr
After 10yr DRIP, annual income (after tax)
$5,415,730.33/yr
PM
Annual income on $10K today (after 15% tax)
$297.03/yr
After 10yr DRIP, annual income (after tax)
$2,127.22/yr
At 15% tax rate, STSA beats the other by $5,413,603.11/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of STSA + PM for your $10,000?

STSA: 50%PM: 50%
100% PM50/50100% STSA
Portfolio after 10yr
$7.81M
Annual income
$3,186,975.03/yr
Blended yield
40.83%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

STSA
Analyst Ratings
4
Buy
9
Hold
Consensus: Hold
Altman Z
-7.4
Piotroski
2/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.9% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

STSA buys
0
PM buys
5
PoliticianChamberTickerTypeAmountDate
Julia Letlow🏢 House$PM▼ Sell$1,001 - $15,0002026-02-05
Julie Johnson🏢 House$PM▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$PM▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$PM▼ Sell$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$PM▼ Sell$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$PM▲ Buy$1,001 - $15,0002025-09-29
Ro Khanna🏢 House$PM▲ Buy$15,001 - $50,0002025-09-05
Ro Khanna🏢 House$PM▲ Buy$15,001 - $50,0002025-08-26
Julie Johnson🏢 House$PM▼ Sell$1,001 - $15,0002025-08-14
Julie Johnson🏢 House$PM▼ Sell$1,001 - $15,0002025-07-22
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSTSAPM
Forward yield136.36%3.49%
Annual dividend / share$1.50$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$15.56M$49.6K
Annual income after 10y$6,371,447.45$2,502.61
Total dividends collected$14.30M$11.8K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldBuy

Year-by-year: STSA vs PM ($10,000, DRIP)

YearSTSA PortfolioSTSA Income/yrPM PortfolioPM Income/yrGap
1← crossover$24,336$13,636.36$11,650$409.56+$12.7KSTSA
2$57,055$31,014.91$13,592$497.49+$43.5KSTSA
3$129,004$67,955.30$15,882$605.21+$113.1KSTSA
4$281,633$143,598.62$18,589$737.41+$263.0KSTSA
5$594,333$292,985.93$21,794$899.94+$572.5KSTSA
6$1,213,779$577,842.64$25,597$1,100.16+$1.19MSTSA
7$2,401,642$1,102,898.48$30,118$1,347.30+$2.37MSTSA
8$4,609,241$2,039,484.49$35,505$1,652.97+$4.57MSTSA
9$8,590,007$3,658,118.87$41,940$2,031.88+$8.55MSTSA
10$15,562,755$6,371,447.45$49,643$2,502.61+$15.51MSTSA

STSA vs PM: Complete Analysis 2026

STSAStock

Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

Full STSA Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this STSA vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

STSA vs SCHDSTSA vs JEPISTSA vs OSTSA vs KOSTSA vs MAINSTSA vs MOSTSA vs BTISTSA vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.